What if the brain's response to stress could be read not in fleeting neurotransmitter bursts, but in the quieting of genes ...

QIAGEN today announced it has entered into a definitive agreement to fully acquire Parse Biosciences, a leading provider of scalable, instrument-free solutions for single-cell research. The ...

Invited presentation followed by panel discussion on the next wave of innovation in immunotherapy of cancer: Paul Peter Tak, M.D., Ph.D., ...

The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...

Although heart cells and skin cells contain identical instructions for creating proteins encoded in their DNA, they're able ...

The immune/tumor microenvironment significantly influences cancer progression and the efficacy of immunotherapeutic ...